ArticleEClinicalMedicine2026

Adalimumab versus placebo as add-on to standard therapy for non-infectious uveitis in the United Kingdom: the ASTUTE randomised controlled trial with treatment run-in.

Andrew D Dick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.